Patents by Inventor Pierre Emile Ulysse Martineau

Pierre Emile Ulysse Martineau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9504676
    Abstract: The present invention relates to the C-13 molecule (methyl 2-{5-[(3-benzyl-4-oxo-2-thioxo-1,3-thiazolidin-5-ylidene)methyl]-2-furyl}-benzoate) and to organic molecules functionally equivalent to the C-13 molecule, capable of inhibiting the binding of an antibody or antibody fragment with the human Syk protein tyrosine kinase, to the use of these molecules for the production of medicaments for the prevention or treatment of diseases dependent on metabolic pathways involving Syk, and also to a method for identifying such molecules.
    Type: Grant
    Filed: October 21, 2013
    Date of Patent: November 29, 2016
    Assignee: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Piona Dariavach, Pierre Emile Ulysse Martineau, Bruno Villoutreix
  • Patent number: 8841238
    Abstract: The present disclosure describes scFv antibody libraries, antibodies isolated from the libraries, and methods of producing and using the same.
    Type: Grant
    Filed: March 17, 2008
    Date of Patent: September 23, 2014
    Assignees: Institut National de la Sante et de la Recherche Medicale (INSERM), Centre National de la Recherche Scientifique (C.N.R.S.), Universite de Strasbourg
    Inventors: Pierre Emile Ulysse Martineau, Etienne Weiss
  • Publication number: 20140179679
    Abstract: The present invention relates to the C-13 molecule (methyl 2-{5-[(3-benzyl-4-oxo-2-thioxo-1,3-thiazolidin-5-ylidene)methyl]-2-furyl}-benzoate) and to organic molecules functionally equivalent to the C-13 molecule, capable of inhibiting the binding of an antibody or antibody fragment with the human Syk protein tyrosine kinase, to the use of these molecules for the production of medicaments for the prevention or treatment of diseases dependent on metabolic pathways involving Syk, and also to a method for identifying such molecules.
    Type: Application
    Filed: October 21, 2013
    Publication date: June 26, 2014
    Applicant: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Piona Dariavach, Pierre Emile Ulysse Martineau, Bruno Villoutreix
  • Publication number: 20110112098
    Abstract: The present invention relates to the C-13 molecule (methyl 2-{5-[(3-benzyl-4-oxo-2-thioxo-1,3-thiazolidin-5-ylidene)methyl]-2-furyl}-benzoate) and to organic molecules functionally equivalent to the C-13 molecule, capable of inhibiting the binding of an antibody or antibody fragment with the human Syk protein tyrosine kinase, to the use of these molecules for the production of medicaments for the prevention or treatment of diseases dependent on metabolic pathways involving Syk, and also to a method for identifying such molecules.
    Type: Application
    Filed: April 8, 2009
    Publication date: May 12, 2011
    Inventors: Piona Dariavach, Pierre Emile Ulysse Martineau, Bruno Villoutreix
  • Publication number: 20100167957
    Abstract: The present disclosure describes scFv antibody libraries, antibodies isolated from the libraries, and methods of producing and using the same.
    Type: Application
    Filed: March 17, 2008
    Publication date: July 1, 2010
    Applicants: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICAL (INSERM), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQ UE (C.N.R.S), UNIVERSITE DE STRASBOURG
    Inventors: Pierre Emile Ulysse Martineau, Etienne Weiss
  • Publication number: 20090143247
    Abstract: The present disclosure describes scFv antibody libraries, antibodies isolated from the libraries, and methods of producing and using the same.
    Type: Application
    Filed: March 17, 2008
    Publication date: June 4, 2009
    Inventors: Pierre Emile Ulysse Martineau, Etienne Weiss